Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy

NCT06495424 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Diabetic Neuropathy
Painful Diabetic Neuropathy

Interventions

DRUG: Capsaicin 8%

Sponsor

Averitas Pharma, Inc.